Madarnas Y - Search Results

1

Neutropenia Prediction Based on First-Cycle Blood Counts Using a FOS-3NN Classifier.

Shirdel EA, Korenberg MJ, Madarnas Y. Shirdel EA, et al. Among authors: madarnas y. Adv Bioinformatics. 2011;2011:172615. doi: 10.1155/2011/172615. Epub 2012 Feb 20. Adv Bioinformatics. 2011. PMID: 22454638 Free PMC article.

2

Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres.

Madarnas Y, Dent SF, Husain SF, Robinson A, Alkhayyat S, Hopman WM, Verreault JL, Vandenberg T. Madarnas Y, et al. Curr Oncol. 2011 Jun;18(3):119-25. doi: 10.3747/co.v18i3.751. Curr Oncol. 2011. PMID: 21655158 Free PMC article.

3

Breast cancer in pregnancy: a literature review.

Molckovsky A, Madarnas Y. Molckovsky A, et al. Among authors: madarnas y. Breast Cancer Res Treat. 2008 Apr;108(3):333-8. doi: 10.1007/s10549-007-9616-6. Epub 2007 May 26. Breast Cancer Res Treat. 2008. PMID: 17530426 Review.

4

Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: a systematic review.

Madarnas Y, Trudeau M, Franek JA, McCready D, Pritchard KI, Messersmith H. Madarnas Y, et al. Cancer Treat Rev. 2008 Oct;34(6):539-57. doi: 10.1016/j.ctrv.2008.03.013. Epub 2008 May 27. Cancer Treat Rev. 2008. PMID: 18502589 Review.

5

Intravital imaging reveals systemic ezrin inhibition impedes cancer cell migration and lymph node metastasis in breast cancer.

Ghaffari A, Hoskin V, Turashvili G, Varma S, Mewburn J, Mullins G, Greer PA, Kiefer F, Day AG, Madarnas Y, SenGupta S, Elliott BE. Ghaffari A, et al. Among authors: madarnas y. Breast Cancer Res. 2019 Jan 24;21(1):12. doi: 10.1186/s13058-018-1079-7. Breast Cancer Res. 2019. PMID: 30678714 Free PMC article.

6

Automated Quantitative Analysis of p53, Cyclin D1, Ki67 and pERK Expression in Breast Carcinoma Does Not Differ from Expert Pathologist Scoring and Correlates with Clinico-Pathological Characteristics.

Cass JD, Varma S, Day AG, Sangrar W, Rajput AB, Raptis LH, Squire J, Madarnas Y, Sengupta SK, Elliott BE. Cass JD, et al. Among authors: madarnas y. Cancers (Basel). 2012 Jul 18;4(3):725-42. doi: 10.3390/cancers4030725. Cancers (Basel). 2012. PMID: 24213463 Free PMC article.

7

Novel prognostic and predictive microRNA targets for triple-negative breast cancer.

Turashvili G, Lightbody ED, Tyryshkin K, SenGupta SK, Elliott BE, Madarnas Y, Ghaffari A, Day A, Nicol CJB. Turashvili G, et al. Among authors: madarnas y. FASEB J. 2018 May 29:fj201800120R. doi: 10.1096/fj.201800120R. Online ahead of print. FASEB J. 2018. PMID: 29812973

8

Immunohistochemical Assessment of Expression of Centromere Protein-A (CENPA) in Human Invasive Breast Cancer.

Rajput AB, Hu N, Varma S, Chen CH, Ding K, Park PC, Chapman JA, Sengupta SK, Madarnas Y, Elliott BE, Feilotter HE. Rajput AB, et al. Among authors: madarnas y. Cancers (Basel). 2011 Dec 6;3(4):4212-27. doi: 10.3390/cancers3044212. Cancers (Basel). 2011. PMID: 24213134 Free PMC article.

9

Models of care for early-stage breast cancer in Canada.

Madarnas Y, Joy AA, Verma S, Sehdev S, Lam W, Sideris L. Madarnas Y, et al. Curr Oncol. 2011 May;18 Suppl 1(Suppl 1):S10-9. doi: 10.3747/co.v18i0.898. Curr Oncol. 2011. PMID: 21698058 Free PMC article.

10

Patient adherence to aromatase inhibitor treatment in the adjuvant setting.

Verma S, Madarnas Y, Sehdev S, Martin G, Bajcar J. Verma S, et al. Among authors: madarnas y. Curr Oncol. 2011 May;18 Suppl 1(Suppl 1):S3-9. doi: 10.3747/co.v18i0.899. Curr Oncol. 2011. PMID: 21698059 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page